MOUNTAIN VIEW, Calif., Sept. 20 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS - News), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products addressing obesity and sexual health, today announced that Leland F. Wilson, President and CEO, will present at the UBS Global Life Sciences Conference. The conference will be held at The Grand Hyatt New York from Monday, September 25th to Thursday, September 28th.
